AutoImmune autoimmune news

AutoImmune said its board approved a plan to dissolve the company and liquidate its assets. Shareholders will vote on the proposal at a special meeting, which is expected in 2Q10. The company plans to distribute all remaining cash after liabilities and other company obligations are paid. The estimated shareholder payout is undisclosed. At Sept. 30, 2009, AutoImmune had $6.8 million in cash and a nine-month operating loss of $233,000. ...